Brief: Vivimed Labs Gets Approval To Manufacture & Market Favipiravir Tablet
10/05/2021 11:16
May 10 (Reuters) - Vivimed Labs Ltd VVMD.NS :
* VIVIMED LABS LTD - GETS APPROVAL TO MANUFACTURE & MARKET
FAVIPIRAVIR TABLET 200 MG & 400 MG FOR INDIAN MARKET
Source text for Eikon: ID:nBSE1cCXcm
Further company coverage: VVMD.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Vivimed Labs
See all newsBrief: Vivimed Labs Says Telangana High Court Grants Interim Stay On Proceedings
Brief: Vivimed Labs Ltd Phaninder Nath Resigns As CFO
Brief: Vivimed Labs CFO And CS Receive Notice From CBI
Brief: Vivimed Labs Says Got Notice From Debt Recovery Tribunal Regarding Application Filed By State Bank Of India
Brief: Vivimed Labs Names Ramakanta Tripathy As CFO